

| Numéro de catalogue | HF013012 |
|---|---|
| Description |
Recombinant Human NPPA Protein, N-GST (HF013012) expressed in E. coli, spanning Ala25-Arg123. Purity: >90% by SDS-PAGE.
Highlights
|
| Système d'expression | E. coli |
| Numéro d'accès | P01160 |
| Longueur de protéine | Ala25-Arg123 |
| Applications | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| Espèces | Human |
| Nature | Recombinant |
| Niveau d'endotoxines | Please contact with the lab for this information. |
| Pureté | >90% as determined by SDS-PAGE. |
| Masse moléculaire prédite | 37.51 kDa |
| Forme | Lyophilized |
| Tampon de stockage | Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1 mM EDTA, 4% Trehalose, 1% Mannitol. Reférez-vous aux informations spécifiques sur le tampon dans la copie papier du datasheet ou dans le COA spécifique au lot. |
| Reconstitution | Reconstitute in sterile water for a stock solution. Adjust the volume of sterile water so that, after reconstitution, the final stock concentration matches the value indicated on the product label or datasheet. RECONSTITUTION PROTOCOL 1. Allow the product to be reconstituted and the reconstitution diluent to reach room temperature. 2. Tap or briefly centrifuge the product vial before opening to dislodge any lyophilized material that may be dispersed on the wall or cap of the vial. 3. Use the diluent and stock concentration recommended in the product datasheet. If preparing a stock concentration higher than recommended, contact Technical Service. 4. After adding the diluent, re-cap the vial and invert gently by hand or place on a slow rocking platform to allow the reconstitution diluent to coat all the surfaces inside the vial. Note: Do not mix by vortexing or by pipetting the material up and down. 5. Allow the vial to sit at room temperature with gentle agitation for at least 15 minutes before aliquotting or using. 6. Store the reconstituted material in single use aliquots in polypropylene or siliconized tubes. Aliquots of 10 μL or larger are recommended. |
| Expédition | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
| Stabilité et stockage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Noms alternatifs | Cardiodilatin, Pro atrial natriuretic factor 1-30, ANF 3-33, proANP, Atrial natriuretic factor prohormone, ANF 1-33, URO, LANH, proANP 31-67, Atrial natriuretic factor, Atrial natriuretic factor 8-33, VSDL, Atriopeptin I, CDD-ANF, ANF 8-33, Atrial natriuretic peptide prohormone, preproCDD-ANF, KP, CDD 95-126, Atrial natriuretic factor 3-33, Pro atrial natriuretic factor 99-126, Atrial natriuretic factor 1-33, proANP 95-126, proANF 99-126, proANF 79-98, Pro atrial natriuretic factor 31-67, ANP, Atriopeptin III, Alpha-hANP, Pro atrial natriuretic peptide 79-98, ANF, preproANP, Atriopeptin II, PND, Pro atrial natriuretic peptide 95-126, Natriuretic peptides A, Pro atrial natriuretic peptide 1-30, CDD-ANP (95-126), proANP 79-98, Pro atrial natriuretic factor 79-98, Atriopeptigen, proANF, CDD, proANF 1-30, LANP, CDD-ANP (99-126), Pro atrial natriuretic peptide 31-67, NPPA, Alpha-atrial natriuretic peptide, proANF 31-67, Cardionatrin, Long-acting natriuretic hormone, proANP 1-30 |
| Contexte | Natriuretic peptides A (NPPA) is a ~16 kDa protein. Hormone that plays a key role in mediating cardio-renal homeostasis, and is involved in vascular remodeling and regulating energy metabolism. Acts by specifically binding and stimulating NPR1 to produce cGMP, which in turn activates effector proteins, such as PRKG1, that drive various biological responses. Regulates vasodilation, natriuresis, diuresis and aldosterone synthesis and is therefore essential for regulating blood pressure, controlling the extracellular fluid volume and maintaining the fluid-electrolyte balance. Also involved in inhibiting cardiac remodeling and cardiac hypertrophy by inducing cardiomyocyte apoptosis and attenuating the growth of cardiomyocytes and fibroblasts. Plays a role in female pregnancy by promoting trophoblast invasion and spiral artery remodeling in uterus, and thus prevents pregnancy-induced hypertension. 1. Birkenfeld, AL. et al. (2005) The Journal of clinical endocrinology and metabolism 90, 3622-8. PMID: 15741263 2. Rubattu, S. et al. (2006) Journal of the American College of Cardiology 48, 499-505. PMID: 16875975 3. Birkenfeld, AL. et al. (2008) Diabetes 57, 3199-204. PMID: 18835931 4. Souza, SC. et al. (2011) Biochemical and biophysical research communications 410, 398-403. PMID: 21672517 5. Bordicchia, M. et al. (2012) The Journal of clinical investigation 122, 1022-36. PMID: 22307324 6. Vesely, DL. et al. (1989) Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 192, 230-5. PMID: 2532366 7. Vesely, DL. et al. (1987) Biochemical and biophysical research communications 148, 1540-8. PMID: 2825692 8. Vesely, DL. et al. (1995) The Journal of endocrinology 146, 373-80. PMID: 7595132 9. Chiou, S. et al. (1995) Endocrinology 136, 2033-9. PMID: 7720651 10. Vesely, DL. et al. (1994) Circulation 90, 1129-40. PMID: 8087923 |
| Note | For research use only. |

SDS-PAGE for Recombinant Human NPPA Protein, N-GST



Contactez-nous pour les devis personnalisés, les demandes en gros et tout autre problème.
Courrier : [email protected]


+86-027-65523339
Bâtiment C, No. 666, Rue Shendunsi, Wuhan, 430206, Chine
中文
English
한국어
日本語
Español
Français
Русский